{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T21:57:08Z","timestamp":1786831028463,"version":"build-2736575974"},"reference-count":27,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1111170"],"award-info":[{"award-number":["1111170"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1146809"],"award-info":[{"award-number":["1146809"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["101908"],"award-info":[{"award-number":["101908"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2022,4,8]]},"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>An adverse interaction whereby opioids impair and delay the gastrointestinal absorption of oral P2Y<jats:sub>12<\/jats:sub> inhibitors has been established, however the clinical significance of this in acute coronary syndrome (ACS) is uncertain. We sought to characterise the relationship between prehospital opioid dose and clinical outcomes in patients with ACS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients given opioid treatment by emergency medical services (EMS) with ACS who underwent percutaneous coronary intervention (PCI) between 1 January 2014 and 31 December 2018 were included in this retrospective cohort analysis using data linkage between the Ambulance Victoria, Victorian Cardiac Outcomes Registry and Melbourne Interventional Group databases. Patients with cardiogenic shock, out-of-hospital cardiac arrest and fibrinolysis were excluded. The primary end point was the risk-adjusted odds of 30-day major adverse cardiac events (MACE) between patients who received opioids and those that did not.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>10 531 patients were included in the primary analysis. There was no significant difference in 30-day MACE between patients receiving opioids and those who did not after adjusting for key patient and clinical factors. Among patients with ST-elevation myocardial infarction (STEMI), there were significantly more patients with thrombolysis in myocardial infarction (TIMI) 0 or 1 flow pre-PCI in a subset of patients with high opioid dose versus no opioids (56% vs 25%, p&lt;0.001). This remained significant after adjusting for known confounders with a higher predicted probability of TIMI 0\/1 flow in the high versus no opioid groups (33% vs 11%, p&lt;0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Opioid use was not associated with 30-day MACE. There were higher rates of TIMI 0\/1 flow pre-PCI in patients with STEMI prescribed opioids. Future prospective research is required to verify these findings and investigate alternative analgesia for ischaemic chest pain.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/emermed-2021-211519","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:56:55Z","timestamp":1653307015000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromes"],"prefix":"10.1136","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-6708","authenticated-orcid":false,"given":"Himawan","family":"Fernando","sequence":"first","affiliation":[{"name":"Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"},{"name":"Central Clinical School, Monash University, Melbourne, Victoria, Australia"},{"name":"Department of Cardiology, Bendigo Health, Bendigo, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Nehme","sequence":"additional","affiliation":[{"name":"Centre for Research and Evaluation, Ambulance Victoria, Melbourne, Victoria, Australia"},{"name":"Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Department of Paramedicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diem","family":"Dinh","sequence":"additional","affiliation":[{"name":"Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1579-9279","authenticated-orcid":false,"given":"Emily","family":"Andrew","sequence":"additional","affiliation":[{"name":"Centre for Research and Evaluation, Ambulance Victoria, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Brennan","sequence":"additional","affiliation":[{"name":"Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Shi","sequence":"additional","affiliation":[{"name":"Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Bloom","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen James","family":"Duffy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"},{"name":"Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Peter","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voltaire","family":"Nadurata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bendigo Health, Bendigo, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"},{"name":"Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Department of Cardiology, Western Health, Melbourne, Victoria, Australia"},{"name":"Department of Medicine-Western Health, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Layland","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peninsula Health, Melbourne, Victoria, Australia"},{"name":"Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Freeman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Eastern Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Van Gaal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Northern Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Bernard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia"},{"name":"Centre for Research and Evaluation, Ambulance Victoria, Melbourne, Victoria, Australia"},{"name":"Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lefkovits","sequence":"additional","affiliation":[{"name":"Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[{"name":"Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stephenson","sequence":"additional","affiliation":[{"name":"Centre for Research and Evaluation, Ambulance Victoria, Melbourne, Victoria, Australia"},{"name":"Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Smith","sequence":"additional","affiliation":[{"name":"Centre for Research and Evaluation, Ambulance Victoria, Melbourne, Victoria, Australia"},{"name":"Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Department of Paramedicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Stub","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"},{"name":"Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Department of Cardiology, Western Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"2025090221475280000_40.2.101.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000659"},{"key":"2025090221475280000_40.2.101.2","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2009.086066"},{"key":"2025090221475280000_40.2.101.3","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2007.047373"},{"key":"2025090221475280000_40.2.101.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.118463"},{"key":"2025090221475280000_40.2.101.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.64.1.53"},{"key":"2025090221475280000_40.2.101.6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2796.1994.tb01105.x","article-title":"Diagnostic potential of chest pain characteristics in coronary care","volume":"235","author":"Eriksson","year":"1994","journal-title":"J Intern Med"},{"key":"2025090221475280000_40.2.101.7","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(89)90020-X"},{"key":"2025090221475280000_40.2.101.8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjcard.2009.11.027","article-title":"Effect of narcotic treatment on outcomes of acute coronary syndromes","volume":"105","author":"Iakobishvili","year":"2010","journal-title":"Am J Cardiol"},{"key":"2025090221475280000_40.2.101.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.02.010"},{"key":"2025090221475280000_40.2.101.10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijcard.2016.06.204","article-title":"Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI","volume":"221","author":"Bellandi","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025090221475280000_40.2.101.11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.hlc.2018.12.015","article-title":"Opioids and ST elevation myocardial infarction: a systematic review","volume":"28","author":"Koh","year":"2019","journal-title":"Heart Lung Circ"},{"key":"2025090221475280000_40.2.101.12","unstructured":"O\u2019Gara PT , Ascheim DD , Casey DE . 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of cardiology Foundation\/American heart association Task force on practice guidelines. Circulation 2013;127."},{"key":"2025090221475280000_40.2.101.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2010.10.002"},{"key":"2025090221475280000_40.2.101.14","unstructured":"Anderson JL . 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of cardiology Foundation\/American heart association Task force on practice guidelines. Circulation 2013:362\u2013425."},{"key":"2025090221475280000_40.2.101.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2010.11.001"},{"key":"2025090221475280000_40.2.101.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.017"},{"key":"2025090221475280000_40.2.101.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029289"},{"key":"2025090221475280000_40.2.101.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(20)32602-4"},{"key":"2025090221475280000_40.2.101.19","doi-asserted-by":"crossref","first-page":"107665","DOI":"10.1016\/j.pharmthera.2020.107665","article-title":"The opioid-P2Y\n                  12\n                inhibitor interaction: Potential strategies to mitigate the interaction and consideration of alternative analgesic agents in myocardial infarction","volume":"217","author":"Fernando","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2025090221475280000_40.2.101.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2009.03.012"},{"key":"2025090221475280000_40.2.101.21","doi-asserted-by":"publisher","DOI":"10.2174\/138161212803582388"},{"key":"2025090221475280000_40.2.101.22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijcard.2016.06.204","article-title":"Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI","volume":"221","author":"Bellandi","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025090221475280000_40.2.101.23","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv567"},{"key":"2025090221475280000_40.2.101.24","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2020-001307"},{"key":"2025090221475280000_40.2.101.25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025090221475280000_40.2.101.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106411","article-title":"An open-label, non-inferiority randomized controlled trial of lidocAine versus opioids in myocardial infarction study (AVOID-2 study) methods paper","volume":"105","author":"Fernando","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"2025090221475280000_40.2.101.27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ehjcvp\/pvaa095","article-title":"Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: opioids aNd crushed ticagrelor in myocardial infarction evaluation (ON-TIME 3) trial","volume":"8","author":"Tavenier","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2021-211519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:48:06Z","timestamp":1756874886000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2021-211519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1,24]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/emermed-2021-211519"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2021-211519","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]}}}